Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
about
Heparin-induced thrombocytopenia in the ICU: an overviewLepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3A comparison of lepirudin and argatroban outcomesArgatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.Diagnosis and management of heparin-induced thrombocytopenia.Direct thrombin inhibitors: pharmacology and clinical relevance.Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.Heparin-induced thrombocytopenia: treatment options and special considerations.Lepirudin in the management of patients with heparin-induced thrombocytopenia.Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.Successful preemptive renal retransplantation in a patient with previous acute graft loss secondary to HIT type II: a case report and review of literature.HIT paradigms and paradoxes.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Impact of Platelet Functional Assays on the Cost of Treating Suspected Heparin-Induced Thrombocytopenia.Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis.Characterization of the threshold response of initiation of blood clotting to stimulus patch size.On-chip titration of an anticoagulant argatroban and determination of the clotting time within whole blood or plasma using a plug-based microfluidic systemDesirudin dosing and monitoring in moderate renal impairment.Argatroban and lepirudin: clinical trials to clinical practice.
P2860
Q21194907-159F75E9-0498-481C-99FF-8DEF7CD2BD2BQ28278419-7477EA0D-82F8-49E8-BAD6-861F10CCC872Q28278668-AE095DD6-43AA-4737-BBE6-F30C029419BAQ33364404-6C3C0E62-59F9-4DE8-B52E-5D37278AFB7CQ33365985-FDA21F20-28D1-4BD0-997E-AF3197E433E8Q33366516-3749A311-DC56-48DC-A93B-D250FF5DEBDAQ33369330-73590163-17C7-4B4D-82F1-B0B8869A8CDEQ33370636-25D0BE4F-BDF8-470B-A550-B61E52261BF6Q33374658-683063BC-EBE3-4662-AE11-EE6F657DFABFQ33385972-74F4F6B6-06E0-4DD9-855E-0D5A20DA7BF2Q33393015-C4474EC4-02EC-410B-8210-F783CF29F712Q33394592-2F2AA7CF-11D6-483B-9787-1625E332FEACQ33396313-435628F8-92AF-4A17-9DC5-515F8B30447CQ33399580-7FFCB1B5-13D6-4899-973C-CE57B7A8B27AQ33413359-9AA6F0ED-C6D9-4879-BAD2-6EDC2CE83042Q33442600-8717E3F4-CCA6-491D-9FD9-FAC10C51BCDCQ36008712-4F99A612-F1FC-41F4-A78D-C08DFE4E610DQ42076867-638833DD-C5F8-4A11-B821-FDE9D52444D0Q43241918-F6DDE37A-08B8-4F32-B07B-0F5E075AE082Q46770280-FFD11941-1FAE-49E2-8274-BF5FF4EBB7FB
P2860
Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Management of heparin-induced ...... n of lepirudin and argatroban.
@ast
Management of heparin-induced ...... n of lepirudin and argatroban.
@en
type
label
Management of heparin-induced ...... n of lepirudin and argatroban.
@ast
Management of heparin-induced ...... n of lepirudin and argatroban.
@en
prefLabel
Management of heparin-induced ...... n of lepirudin and argatroban.
@ast
Management of heparin-induced ...... n of lepirudin and argatroban.
@en
P1433
P1476
Management of heparin-induced ...... n of lepirudin and argatroban.
@en
P356
10.1016/S0049-3848(03)00336-0
P577
2003-05-01T00:00:00Z